DiscoverGuidePost, A Podcast Series from The CRISPR JournalEp. 13: Edward Lanphier, chief editing officer
Ep. 13: Edward Lanphier, chief editing officer

Ep. 13: Edward Lanphier, chief editing officer

Update: 2019-08-21
Share

Description

The recently retired founding CEO of Sangamo Therapeutics, Edward Lanphier, shares stories from two decades at the helm of the first biotech company to develop and take genome editing, using zinc finger nucleases, into the clinic.
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Ep. 13: Edward Lanphier, chief editing officer

Ep. 13: Edward Lanphier, chief editing officer

The CRISPR Journal